Ultralife CorporationULBINASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -9.61% | -1.56% | +21.03% | +12.98% | +21.51% |
| Gross Profit Growth | -11.17% | -7.04% | +11.12% | +0.33% | +10.79% |
| EBITDA Growth | -54.24% | -45.76% | -5.14% | -28.58% | -56.58% |
| Operating Income Growth | -76.07% | -59.61% | -16.34% | -42.40% | -286.11% |
| Net Income Growth | -80.60% | -93.25% | -35.49% | -70.39% | -572.87% |
| EPS Growth | -81.07% | -93.50% | -38.89% | -70.67% | -572.90% |
| EPS Diluted Growth | -81.25% | -93.18% | -38.89% | -70.67% | -579.08% |
| Weighted Average Shares Growth | +2.38% | +1.78% | +1.45% | +0.40% | +0.13% |
| Weighted Average Shares Diluted Growth | +3.50% | +1.75% | +0.98% | -1.00% | -1.35% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +25.25% | +0.00% | -33.50% | -96.33% |
| Free Cash Flow Growth | +0.00% | +70.99% | +0.00% | -43.55% | -119.77% |
| Receivables Growth | +2.08% | -7.53% | +2.22% | +4.08% | +11.44% |
| Inventory Growth | -5.66% | +21.67% | +9.20% | +22.19% | +19.90% |
| Asset Growth | -2.08% | +23.66% | +23.93% | +30.12% | +28.88% |
| Book Value per Share Growth | +7.98% | +5.04% | +4.36% | +3.51% | +1.94% |
| Debt Growth | -56.92% | +100.22% | +103.43% | +235.95% | +346.18% |
| R&D Expense Growth | +12.41% | +30.35% | +36.90% | +16.07% | +35.89% |
| SG&A Expenses Growth | +5.20% | +13.73% | +22.85% | +24.39% | +27.10% |